Subacute Invasive Pulmonary Aspergillosis (IPA) Is a Challenging Diagnosis

Marco Fernandes1, Cristiana Camacho1, Cláudio Gouveia1

  • 1Internal Medicine, Hospital de São Francisco Xavier, Lisbon, PRT.

Cureus
|December 26, 2022
PubMed

Insights

This case report highlights a fatal outcome of invasive pulmonary aspergillosis (IPA) in an immunocompromised patient. Early suspicion and diagnosis are crucial for Aspergillus infections, especially in those with risk factors like corticosteroid use.

Area of Science:

  • Medical Mycology
  • Pulmonology
  • Infectious Diseases

Background:

  • Aspergillus infections present diverse clinical manifestations and prognoses influenced by host immunity.
  • Invasive pulmonary aspergillosis (IPA) diagnosis is challenging due to insidious onset, especially in immunocompromised individuals.

Observation:

  • A 78-year-old male with asthma-COPD overlap, idiopathic pulmonary fibrosis, and long-term corticosteroid use presented with dyspnea and wasting syndrome.
  • Initial presentation revealed Candida albicans; subsequent deterioration led to the identification of Aspergillus in bronchoalveolar lavage, confirming IPA.
  • The patient exhibited symptoms mimicking neoplasia, including Syndrome of Inappropriate Antidiuretic Hormone secretion (SIADH), complicating the diagnostic process.

Findings:

  • Pathological anatomy confirmed invasive pulmonary aspergillosis (IPA) as the definitive diagnosis.
  • Despite treatment with voriconazole, the patient experienced an unfavorable outcome, succumbing to complications including cachexia and gastrointestinal bleeding.

Implications:

  • This case underscores the critical need for high clinical suspicion of Aspergillus infection in patients with risk factors such as chronic corticosteroid use and structural lung disease.
  • Late diagnosis of IPA can lead to severe complications and mortality, emphasizing the importance of timely diagnostic interventions.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
344
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
298
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
186
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
296
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
409